Confo Therapeutics
Caroline Segers is a Senior Research Associate at Confo Therapeutics, where responsibilities include overseeing the Internal Physical Control - Radioactive room and conducting research. Prior experience includes a Masterstudent role at the KU Leuven research group, focusing on diabetic retinopathy, and internships at Bayer and Galapagos, where lab work and project management were key contributions. Caroline Segers holds a Master's degree in Biochemistry and Biotechnology and a Bachelor's degree in Biology from KU Leuven. Expertise encompasses both in vivo and in vitro techniques, including fluorotron, HRA, ERG, and various molecular biology methods.
This person is not in any offices
Confo Therapeutics
1 followers
Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery.